laitimes

Nie Zaijian, Chairman of Sanyuan Biotech: The company is committed to the production of erythritol and the research and development of new multifunctional sugars

author:China Securities Journal

Gao Jiachen China Securities News · China Securities Network

China Securities Network News (reporter Gao Jiachen) On January 21, Shandong Sanyuan Biotechnology Co., Ltd. (hereinafter referred to as "Sanyuan Biotechnology") made an initial public offering of shares and was listed on the ChiNext board. Nie Zaijian, chairman of Sanyuan Biologics, said that the company is a biological high-tech enterprise integrating scientific research, production and sales based on the "fermentation method production of erythritol project", and is committed to the production of erythritol and the research and development of new multifunctional sugars.

Read on